中度至重度急性呼吸窘迫综合征中的肥胖和炎症反应:单一中心试点研究
Adriano Peris1, Marzia Del Re2, Manuela Bonizzoli3
1Unit of Intensive Care and Regional ECMO Referral Center, Careggi University Hospital, Florence, Italy - aperis@libero.it.
Minerva medica
|May 19, 2025
概括
急性呼吸困扰综合征 (ARDS) 患者的肥胖会改变炎症反应. 肥胖的ARDS患者表现出矩阵金属蛋白酶-7 (MMP-7) 和托尔类受体2 (TLR-2) 水平的增加,这表明一种独特的炎症途径.
科学领域:
- 关键护理医学 关键护理医学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 肥胖与急性呼吸窘迫综合征 (ARDS) 的死亡率降低有关,但潜在的机制尚不清楚.
- 了解肥胖ARDS患者的炎症反应对于向治疗至关重要.
研究的目的:
- 为了研究肥胖患者与患有中度至重度ARDS的非肥胖患者的血生物标志物水平.
- 评估72小时内特定炎症标志物的变化,与肥胖状况相关.
主要方法:
- 血中测量了介质素-8 (IL-8),矩阵金属蛋白酶-7 (MMP-7),托尔类受体2 (TLR-2),瘤缩因子-α (TNF-α) 和公素 (PCT) 的水平.
- 在20名机械通风ARDS患者的基线和72小时内评估了生物标志物水平.
- 患者被分为肥胖 (40%) 和正常体重子组进行比较.
主要成果:
- 在肥胖和正常体重的ARDS患者之间没有观察到基线特征或ICU死亡率的显著差异.
- 虽然总体生物标志物水平在基线或72小时之间没有显著差异,但肥胖患者在72小时后与基线相比,MMP-7和TLR-2显著增加.
- 正常体重的患者没有表现出MMP-7和TLR-2水平的增加.
结论:
- 患有中度至重度ARDS的肥胖患者表现出改变的炎症反应,其特征是MMP-7和TLR-2水平增加.
- 这些发现表明,肥胖ARDS患者的明显炎症途径需要进一步调查.
- 需要进行更大的队列研究来验证这些初步结果并阐明临床影响.
相关概念视频
01:24Obesity
350
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
350
01:21Acute Respiratory Failure-II
157
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
157
01:30Acute Respiratory Failure-III
147
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
147
01:23Acute Respiratory Failure-IV
115
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
115
01:29Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K